Gilead Sciences, the company that makes the antiviral drug remdesivir, announced it is about to start trials of an inhaled version of the medication
- Gilead Sciences, the company that makes the antiviral drug remdesivir, announced on Monday that it is about to start trials of an inhaled version of the medication.
"After receiving the green light from the FDA to move forward, Gilead is about to start trials of an inhaled version of remdesivir. We will screen healthy volunteers for Phase 1 trials this week and hope to begin studies in patients with COVID-19 in August," Daniel O'Day, Gilead Sciences chairman and CEO, said in an open letter on Monday.
The letter went on to explain how there are also plans to study remdesivir in treating COVID-19 earlier in the progression of the disease, in combination with other therapies and in additional patient groups. Last week, Gilead announced it would begin advanced trials of the drug in children.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cops nab foreigner for selling illegal COVID-19 medicine in ParañaqueMANILA, Philippines — Police officers arrested a Chinese man in Parañaque City on Saturday afternoon for allegedly selling unregistered medicine that allegedly treats the coronavirus disease
Read more »
DOH to validate European study linking blood type to COVID-19 riskMANILA, Philippines — The Department of Health (DOH) is now gathering evidence that could corroborate a report from Europe that people with certain blood types are more susceptible to infection from
Read more »
132 BFP-Region 6 staff negatibo sa COVID-19
Read more »
DOH: 25 bagong kaso ng COVID-19 naitala sa CARAGA
Read more »
Swiss giant Novartis halts COVID-19 hydroxychloroquine studyNot enough patients are enrolling in clinical trials
Read more »